Only third of convalescent plasma suitable for Covid-19 treatment

Ljubljana, 3 March - Only a third of plasma taken by the Blood Transfusion Centre from those who recovered from Covid-19 contains sufficient amounts of neutralising antibodies to be used as treatment for Covid-19, while 12% of those who recovered did not even develop antibodies.